UNICREDIT BANK/CALL/FRESENIUS MEDICAL CARE/40/0.1/19.03.25 Share Price

Warrant

DE000HD3XU73

Market Closed - BOERSE MUENCHEN 20:46:34 05/07/2024 BST
0.27 EUR +3.85% Intraday chart for UNICREDIT BANK/CALL/FRESENIUS MEDICAL CARE/40/0.1/19.03.25
3 months-3.57%
Date Price Change
05/07/24 0.27 +3.85%
04/07/24 0.26 +4.00%
03/07/24 0.25 0.00%
02/07/24 0.25 -7.41%
01/07/24 0.27 0.00%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 08:46 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HD3XU7
ISINDE000HD3XU73
Date issued 20/03/2024
Strike 40
Maturity 19/03/2025 (256 Days)
Parity 10 : 1
Emission price 0.35
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.61
Lowest since issue 0.24
Spread 0.01
Spread %3.70%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.16 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.55%
Consensus